Feasibility of a Sensor-less Sleep Monitor (Somnofy®) in Diagnosis and Follow-up in Obstructive Sleep Apnea.
Long Distance Diagnostics of Sleep Apnea With Objective Sleep Data From a Sensor-less Monitor - a Feasibility Study
2 other identifiers
observational
65
1 country
1
Brief Summary
To evaluate the feasibility of a sensor-less sleep monitor (Somnofy®) in diagnosis and follow-up in obstructive sleep apnea. The study will explore the monitor's usefulness in detection of apnea during sleep, and compare the data to standard diagnostic registrations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 9, 2021
CompletedFirst Posted
Study publicly available on registry
September 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 7, 2023
CompletedMarch 20, 2023
March 1, 2023
1.3 years
September 9, 2021
March 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Apnea/hypopnea index
Apnea/hypopnea index defined as the number of apneas or hypopneas per hours of sleep
72 hours
Secondary Outcomes (1)
Sleep score
12 weeks
Study Arms (2)
Sleep apnea group
Patients with undiagnosed suspected sleep apnea who are referred to Levanger Hospital for respiratory polygraphy
Control group
partners of patients with undiagnosed suspected sleep apnea who are referred to Levanger Hospital for respiratory polygraphy
Interventions
Registration of sleep score and apneas with radar sensor technology at time of primary investigation and 12 weeks after treatment initiation with continuous positive airway pressure (CPAP)
Eligibility Criteria
Patents with undiagnosed suspected sleep apnea who are referred to Levanger Hospital for respiratory polygraphy, and their partners
You may qualify if:
- referred to the pulmonology department in the participating hospital (Sykehuset Levanger) with suspected sleep apnea
- able to sign an informed consent
You may not qualify if:
- Pregnancy
- Serious disease which could affect ability to complete the study
- Complicated sleep disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Helse Nord-Trøndelag HFlead
- Norwegian University of Science and Technologycollaborator
- VitalThingscollaborator
Study Sites (1)
Department of Pulmonology, Levanger Hospital, North Trøndelag Hospital Trust
Levanger, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Øystein Risa, PhD
NTNU, Fac of Med and Health Sci, Dept of Circulation and Medical Imaging
- STUDY DIRECTOR
Carl Platou, MD
North Trøndelag Hospital Trust
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2021
First Posted
September 17, 2021
Study Start
September 1, 2021
Primary Completion
December 31, 2022
Study Completion
March 7, 2023
Last Updated
March 20, 2023
Record last verified: 2023-03